Limit this search to....

Combined Estrogen-Progestogen Contraceptives and Combined Estrogen-Progestogen Menopausal Therapy
Contributor(s): The International Agency for Research on (Author)
ISBN: 9283212916     ISBN-13: 9789283212911
Publisher: World Health Organization
OUR PRICE:   $62.70  
Product Type: Paperback
Published: December 2008
Qty:
Temporarily out of stock - Will ship within 2 to 5 weeks
Annotation: This ninety-first volume of "IARC Monographs" contains evaluations of the carcinogenic hazard to humans of combined estrogen-progestogen contraceptives and combined estrogen-protestogen menopausal therapy.
Additional Information
BISAC Categories:
- Medical | Nursing - Oncology & Cancer
- Medical | Oncology - General
- Medical | Public Health
Dewey: 616.994
Physical Information: 537 pages
 
Descriptions, Reviews, Etc.
Publisher Description:
This ninety-first volume of IARC Monographs contains evaluations of the carcinogenic hazard to humans of combined estrogen-progestogen contraceptives and combined estrogen-protestogen menopausal therapy.

The hormonal drugs reviewed in this volume involve co-administration of an estrogen and a progestogen.
Studies that did not provide information on the use of combined estrogen-progestogen agents are not reviewed.
It should also be noted that this volume reviews only studies that are publicly available and therefore does not include pharmaceutical test results that are not in the public domain.

The evaluations developed in this volume identify specific forms of cancer for which the risk is increased or decreased by combined estrogen-progestogen contraceptives and provide information that will help address the health concerns and well-being of hundred of millions of women worldwide.

Contributor Bio(s): The International Agency for Research on Cancer: - The International Agency for Research on Cancer (IARC) is part of the World Health Organization. IARC's mission is to coordinate and conduct research on the causes of human cancer, the mechanisms of carcinogenesis, and to develop scientific strategies for cancer control. The Agency is involved in both epidemiological and laboratory research and disseminates scientific information through publications, meetings, courses, and fellowships.